Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis is well-positioned for future growth, with a clear focus on delivering precision and safety for patients in interventional procedures through their innovative robotic technologies, strong recurring revenue streams, and significant progress in ramping production for their MAGiC catheter. Despite a slight revenue miss in Q2, the company has received positive feedback on its MAGiC catheter and anticipates further sequential improvements in recurring revenue in H2. With key milestones expected in the form of first US sales of their GenesisX robot and Synchrony system, and a goal of reaching production of 500 MAGiC catheters per month by YE, Stereotaxis remains an attractive investment opportunity with significant upside potential.

Bears say

Stereotaxis is facing several challenges that could negatively affect its performance, including slow adoption of new technologies by healthcare providers, collaboration risk with other manufacturers and producers, long and variable sales cycles, installation and regulatory risks, and a competitive economic environment. The company has also revised its revenue guidance for 2026 to $35M, below its previous projection of $40M, due to delays in system sales. Additionally, while the recent acquisition of Robocath may provide some revenue in the short term, the company's primary focus will be on developing its next-generation system.

Stereotaxis Inc (STXS) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 4 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.